CNTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.59%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $15,731,425.08

Centessa Pharmaceuticals Insider Trading History Chart

Centessa Pharmaceuticals Share Price & Price History

^$16.35

▼ -0.285 (-1.71%)

As of 03/25/2025 11:12 AM ET

Days: 30 | 90 | 365

Centessa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/20/2025	Saurabh Saha	CEO	Sell	55,000	$16.69	$917,950.00	276,017
3/17/2025	David M Chao	Insider	Sell	7,000	$17.17	$120,190.00	225,007
3/17/2025	Iqbal J. Hussain	General Counsel	Sell	6,000	$16.45	$98,700.00	105,386
2/20/2025	Saurabh Saha	CEO	Sell	55,000	$15.93	$876,150.00	331,017
2/18/2025	Iqbal J. Hussain	General Counsel	Sell	6,000	$16.18	$97,080.00	105,386
2/10/2025	Karen M. Anderson	Insider	Sell	429	$18.99	$8,146.71	54,322
2/7/2025	Karen M. Anderson	Insider	Sell	30,526	$19.03	$580,909.78	54,322
2/3/2025	Karen M. Anderson	Insider	Sell	6,471	$16.86	$109,101.06	54,322
2/3/2025	Tia L. Bush	CTO	Sell	11,000	$16.86	$185,460.00	121,503
1/27/2025	Gregory M. Weinhoff	Insider	Sell	11,742	$16.47	$193,390.74	159,782
1/21/2025	Saurabh Saha	CEO	Sell	55,000	$15.77	$867,350.00	429,398
1/15/2025	Iqbal J. Hussain	General Counsel	Sell	6,000	$15.29	$91,740.00	118,265
12/26/2024	Gregory M. Weinhoff	Insider	Sell	10,000	$17.04	$170,400.00	183,266
12/20/2024	Saurabh Saha	CEO	Sell	55,000	$17.44	$959,200.00	520,661
12/17/2024	Karen M. Anderson	Insider	Sell	10,624	$17.32	$184,007.68	71,525
12/17/2024	Tia L. Bush	CTO	Sell	17,813	$18.00	$320,634.00	147,615
12/16/2024	Iqbal J. Hussain	General Counsel	Sell	77,705	$16.39	$1,273,584.95	125,785
12/13/2024	Karen M. Anderson	Insider	Sell	5,876	$17.01	$99,950.76	71,525
12/6/2024	Saurabh Saha	CEO	Sell	87,496	$18.46	$1,615,176.16	575,661
11/25/2024	Gregory M. Weinhoff	Insider	Sell	10,000	$17.66	$176,600.00	183,266
11/25/2024	Saurabh Saha	CEO	Sell	299	$18.23	$5,450.77	575,661
11/22/2024	Saurabh Saha	CEO	Sell	1,671	$18.24	$30,479.04	575,661
11/20/2024	Saurabh Saha	CEO	Sell	55,000	$16.89	$928,950.00	575,661
10/25/2024	Gregory M. Weinhoff	Insider	Sell	11,742	$15.38	$180,591.96	183,266
10/23/2024	Saurabh Saha	CEO	Sell	2,592	$15.32	$39,709.44	630,661
10/21/2024	Saurabh Saha	CEO	Sell	22,205	$15.80	$350,839.00	663,456
9/25/2024	Gregory M. Weinhoff	Insider	Sell	16,619	$15.69	$260,752.11	206,750
9/20/2024	Saurabh Saha	CEO	Sell	55,000	$16.53	$909,150.00	721,924
9/10/2024	Saurabh Saha	CEO	Sell	175,000	$16.52	$2,891,000.00	776,924
9/9/2024	Gregory M. Weinhoff	Insider	Sell	25,000	$15.00	$375,000.00	223,369
8/22/2024	Gregory M. Weinhoff	Insider	Sell	12,198	$12.17	$148,449.66	241,171
8/22/2024	Saurabh Saha	CEO	Sell	506	$12.23	$6,188.38	823,575
8/20/2024	Saurabh Saha	CEO	Sell	4,169	$12.32	$51,362.08	827,755
3/25/2024	Karen M. Anderson	Insider	Sell	51,160	$11.88	$607,780.80	71,525
2/1/2024	Harris Rotman	SVP	Sell	4,267	$8.10	$34,562.70	62,625
9/20/2023	Harris Rotman	SVP	Sell	37,484	$6.29	$235,774.36	33,500
6/1/2023	Antoine Yver	EVP	Sell	6,500	$4.45	$28,925.00	783,066
5/24/2023	Tia L. Bush	Insider	Sell	8,000	$4.48	$35,840.00	157,102
5/1/2023	Antoine Yver	EVP	Sell	6,800	$4.42	$30,056.00	789,566
1/4/2023	Antoine Yver	EVP	Sell	6,970	$3.18	$22,164.60	751,913
12/1/2022	Antoine Yver	EVP	Sell	9,400	$3.91	$36,754.00	761,151
11/1/2022	Antoine Yver	EVP	Sell	9,700	$4.03	$39,091.00	765,059
10/3/2022	Antoine Yver	EVP	Sell	12,524	$3.92	$49,094.08	774,759
10/3/2022	David M Chao	Insider	Sell	4,167	$3.95	$16,459.65	222,932
10/3/2022	Gregory M. Weinhoff	CFO	Sell	4,901	$3.95	$19,358.95	231,099
10/3/2022	Iqbal J. Hussain	General Counsel	Sell	4,563	$3.95	$18,023.85	154,712
10/3/2022	Thomas Templeman	CTO	Sell	2,455	$3.95	$9,697.25	135,792
9/30/2022	Antoine Yver	EVP	Sell	2,468	$4.07	$10,044.76	787,283
9/30/2022	David M Chao	Insider	Sell	3,401	$4.07	$13,842.07	227,099
9/30/2022	Gregory M. Weinhoff	CFO	Sell	4,000	$4.07	$16,280.00	236,000
9/30/2022	Iqbal J. Hussain	General Counsel	Sell	3,725	$4.07	$15,160.75	159,275
9/30/2022	Thomas Templeman	CTO	Sell	2,003	$4.07	$8,152.21	138,247
8/1/2022	Antoine Yver	EVP	Sell	10,423	$4.45	$46,382.35	800,174
7/18/2022	Antoine Yver	EVP	Sell	20,000	$4.87	$97,400.00	810,597
7/1/2022	Antoine Yver	EVP	Sell	9,100	$5.03	$45,773.00	730,597
6/24/2022	Saurabh Saha	CEO	Buy	10,000	$4.63	$46,300.00	38,000
6/17/2022	Antoine Yver	EVP	Sell	9,200	$4.68	$43,056.00	739,697
5/17/2022	Antoine Yver	EVP	Sell	20,222	$5.42	$109,603.24	813,675

See Full Table

SEC Filings (Institutional Ownership Changes) for Centessa Pharmaceuticals (NASDAQ:CNTA)

82.01% of Centessa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Centessa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	115,107	$1.93M	0.0%	+14.4%	0.087%
2/19/2025	GF Fund Management CO. LTD.	1,872	$31K	0.0%	N/A	0.001%
2/17/2025	Woodline Partners LP	545,645	$9.14M	0.1%	+5.7%	0.414%
2/17/2025	Squarepoint Ops LLC	26,806	$0.45M	0.0%	+33.2%	0.020%
2/17/2025	Two Sigma Investments LP	37,900	$0.64M	0.0%	-63.5%	0.029%
2/17/2025	Stempoint Capital LP	641,964	$10.75M	2.7%	+667.3%	0.487%
2/17/2025	Shay Capital LLC	14,269	$0.24M	0.0%	N/A	0.011%
2/17/2025	Point72 Asset Management L.P.	3,426,599	$57.40M	0.1%	+26.2%	2.599%
2/17/2025	OMERS ADMINISTRATION Corp	10,200	$0.17M	0.0%	N/A	0.008%
2/17/2025	Millennium Management LLC	398,451	$6.67M	0.0%	+73.0%	0.302%
2/17/2025	Lazard Asset Management LLC	73,189	$1.23M	0.0%	N/A	0.056%
2/17/2025	Janus Henderson Group PLC	4,909,487	$82.22M	0.0%	+279.2%	3.724%
2/17/2025	Farallon Capital Management LLC	3,498,709	$58.60M	0.3%	+24.3%	2.654%
2/17/2025	Fred Alger Management LLC	190,451	$3.19M	0.0%	+7.3%	0.144%
2/17/2025	DAFNA Capital Management LLC	47,453	$0.80M	0.2%	-60.6%	0.036%
2/17/2025	DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main	303,479	$5.08M	0.0%	N/A	0.230%
2/17/2025	Driehaus Capital Management LLC	1,598,183	$26.77M	0.2%	-26.1%	1.212%
2/17/2025	Cubist Systematic Strategies LLC	45,885	$0.77M	0.0%	-65.8%	0.035%
2/17/2025	Cutter Capital Management LP	147,076	$2.46M	1.0%	N/A	0.112%
2/17/2025	Avidity Partners Management LP	1,165,800	$19.53M	1.9%	-45.3%	0.884%
2/17/2025	Balyasny Asset Management L.P.	175,428	$2.94M	0.0%	-74.3%	0.133%
2/17/2025	Bank of America Corp DE	43,708	$0.73M	0.0%	-86.1%	0.033%
2/17/2025	BNP Paribas Financial Markets	9,672	$0.16M	0.0%	N/A	0.007%
2/17/2025	Ameriprise Financial Inc.	19,122	$0.32M	0.0%	N/A	0.015%
2/17/2025	Allostery Investments LP	284,517	$4.77M	4.9%	N/A	0.216%
2/17/2025	Ally Bridge Group NY LLC	244,538	$4.10M	3.4%	-21.0%	0.185%
2/17/2025	5AM Venture Management LLC	830,945	$13.92M	3.3%	-35.3%	0.630%
2/14/2025	Schonfeld Strategic Advisors LLC	365,200	$6.12M	0.0%	N/A	0.277%
2/14/2025	First Light Asset Management LLC	5,805,184	$97.24M	9.2%	-2.3%	4.403%
2/14/2025	Foresite Capital Management VI LLC	1,253,379	$20.99M	9.4%	N/A	0.951%
2/14/2025	The Manufacturers Life Insurance Company	317,329	$5.32M	0.0%	+19.8%	0.241%
2/14/2025	Boothbay Fund Management LLC	41,900	$0.70M	0.0%	N/A	0.032%
2/14/2025	Virtus ETF Advisers LLC	4,214	$71K	0.0%	-54.6%	0.003%
2/14/2025	Lord Abbett & CO. LLC	440,495	$7.38M	0.0%	+63.6%	0.334%
2/14/2025	Voya Investment Management LLC	29,670	$0.50M	0.0%	N/A	0.023%
2/14/2025	Blue Owl Capital Holdings LP	220,000	$3.69M	0.9%	-13.7%	0.167%
2/14/2025	Adage Capital Partners GP L.L.C.	5,119,027	$85.74M	0.1%	+22.0%	3.882%
2/14/2025	T. Rowe Price Investment Management Inc.	3,418,600	$57.26M	0.0%	-3.9%	2.593%
2/14/2025	Price T Rowe Associates Inc. MD	5,364,392	$89.85M	0.0%	+14.6%	4.069%
2/14/2025	Silverarc Capital Management LLC	598,952	$10.03M	2.2%	-19.6%	0.454%
2/14/2025	Diadema Partners LP	131,862	$2.21M	0.9%	N/A	0.100%
2/13/2025	Marshall Wace LLP	139,732	$2.34M	0.0%	-22.7%	0.106%
2/13/2025	Affinity Asset Advisors LLC	1,095,924	$18.36M	2.5%	+13.5%	0.831%
2/13/2025	Jump Financial LLC	25,700	$0.43M	0.0%	-47.7%	0.019%
2/13/2025	XTX Topco Ltd	22,680	$0.38M	0.0%	+122.9%	0.017%
2/13/2025	Barclays PLC	5,302	$89K	0.0%	+1,414.9%	0.004%
2/13/2025	Renaissance Technologies LLC	178,600	$2.99M	0.0%	-14.8%	0.135%
2/13/2025	Rathbones Group PLC	16,650	$0.28M	0.0%	-45.2%	0.013%
2/13/2025	Legal & General Group Plc	75,451	$1.26M	0.0%	N/A	0.057%
2/13/2025	ADAR1 Capital Management LLC	154,027	$2.58M	0.5%	+561.0%	0.117%
2/12/2025	Trexquant Investment LP	261,184	$4.38M	0.1%	+52.8%	0.198%
2/12/2025	Geode Capital Management LLC	57,257	$0.96M	0.0%	+1.2%	0.043%
2/12/2025	Franklin Resources Inc.	2,308,546	$38.67M	0.0%	+0.3%	1.751%
2/12/2025	Wellington Management Group LLP	115,107	$1.93M	0.0%	+14.4%	0.087%
2/12/2025	JPMorgan Chase & Co.	190,385	$3.19M	0.0%	+40.1%	0.144%
2/11/2025	American Century Companies Inc.	1,079,708	$18.09M	0.0%	-5.3%	0.819%
2/11/2025	Platinum Investment Management Ltd.	370,278	$6.20M	0.4%	-13.8%	0.281%
2/6/2025	Atria Investments Inc	13,774	$0.23M	0.0%	-19.6%	0.010%
1/31/2025	HighMark Wealth Management LLC	166,135	$2.78M	1.6%	-0.6%	0.126%
1/28/2025	Advisors Preferred LLC	2,372	$42K	0.0%	-47.9%	0.002%
1/24/2025	China Universal Asset Management Co. Ltd.	18,909	$0.32M	0.0%	+39.1%	0.014%
1/3/2025	GAMMA Investing LLC	3,837	$64K	0.0%	+29.1%	0.003%
12/26/2024	JPMorgan Chase & Co.	135,903	$2.17M	0.0%	+1,969.2%	0.103%
12/13/2024	Lord Abbett & CO. LLC	269,205	$4.31M	0.0%	N/A	0.204%
12/13/2024	Exome Asset Management LLC	138,152	$2.21M	1.5%	-49.7%	0.105%
11/27/2024	Franklin Resources Inc.	2,302,546	$38.36M	0.0%	+99.1%	1.749%
11/16/2024	Geode Capital Management LLC	56,597	$0.91M	0.0%	+68.7%	0.050%
11/15/2024	XTX Topco Ltd	10,174	$0.16M	0.0%	-37.9%	0.009%
11/15/2024	Jane Street Group LLC	177,260	$2.83M	0.0%	N/A	0.156%
11/15/2024	Wellington Management Group LLP	100,613	$1.61M	0.0%	N/A	0.089%
11/15/2024	State Street Corp	48,592	$0.78M	0.0%	N/A	0.043%
11/15/2024	RTW Investments LP	50,000	$0.80M	0.0%	N/A	0.044%
11/15/2024	Point72 Asset Management L.P.	2,715,663	$43.42M	0.1%	+54.1%	2.397%
11/15/2024	Janus Henderson Group PLC	1,294,864	$20.70M	0.0%	N/A	1.143%
11/15/2024	HighVista Strategies LLC	46,116	$0.74M	0.3%	N/A	0.041%
11/15/2024	Baker BROS. Advisors LP	1,227,178	$19.62M	0.2%	+123.4%	1.083%
11/14/2024	PFM Health Sciences LP	269,158	$4.30M	0.2%	-57.7%	0.238%
11/14/2024	Fred Alger Management LLC	177,553	$2.84M	0.0%	+1,515.1%	0.157%
11/14/2024	Walleye Capital LLC	11,721	$0.19M	0.0%	N/A	0.010%
11/14/2024	Suvretta Capital Management LLC	70,000	$1.12M	0.0%	N/A	0.062%
11/14/2024	Ally Bridge Group NY LLC	309,614	$4.95M	2.7%	N/A	0.273%
11/13/2024	FMR LLC	2,916,494	$46.64M	0.0%	+4.6%	2.574%
11/13/2024	The Manufacturers Life Insurance Company	264,969	$4.24M	0.0%	+88.1%	0.234%
11/5/2024	GSA Capital Partners LLP	93,658	$1.50M	0.1%	+66.1%	0.083%
11/1/2024	Atria Investments Inc	17,134	$0.27M	0.0%	+7.0%	0.015%
10/25/2024	China Universal Asset Management Co. Ltd.	13,593	$0.22M	0.0%	+99.7%	0.014%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,556	$40K	0.0%	+47.7%	0.003%
10/17/2024	Harbour Capital Advisors LLC	16,675	$0.26M	0.1%	N/A	0.017%
10/7/2024	GAMMA Investing LLC	2,972	$48K	0.0%	+103.1%	0.003%
9/16/2024	Cubist Systematic Strategies LLC	26,073	$0.24M	0.0%	-64.1%	0.026%
8/20/2024	Nantahala Capital Management LLC	450,000	$4.06M	0.2%	N/A	0.448%
8/19/2024	Point72 Asset Management L.P.	1,762,004	$15.91M	0.0%	-22.0%	1.754%
8/16/2024	Perceptive Advisors LLC	3,933,307	$35.52M	0.8%	+27.6%	3.914%
8/16/2024	Quarry LP	9,608	$87K	0.0%	+47.8%	0.010%
8/16/2024	Driehaus Capital Management LLC	2,092,011	$18.89M	0.2%	+89.5%	2.082%
8/15/2024	The Manufacturers Life Insurance Company	140,894	$1.27M	0.0%	+30.4%	0.140%
8/15/2024	Affinity Asset Advisors LLC	1,135,702	$10.26M	1.2%	+36.7%	1.130%
8/14/2024	Fred Alger Management LLC	10,993	$99K	0.0%	N/A	0.011%
8/14/2024	Sandia Investment Management LP	10,000	$90K	0.1%	N/A	0.010%
8/14/2024	Cubist Systematic Strategies LLC	26,073	$0.24M	0.0%	-64.1%	0.026%

Data available starting January 2016

See Full Table

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Today's Range

Now: $16.35

$16.01

$16.62

50 Day Range

MA: $16.49

$14.84

$19.03

52 Week Range

Now: $16.35

$7.75

$19.09

Volume

49,522 shs

Average Volume

528,206 shs

Market Capitalization

$2.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Who are the company insiders with the largest holdings of Centessa Pharmaceuticals?: Centessa Pharmaceuticals' top insider shareholders include:
Saurabh Saha (CEO)
Antoine Yver (EVP)
Gregory M Weinhoff (Insider)
David M Chao (Insider)
Tia L Bush (Insider)
Tia L Bush (CTO)
Iqbal J Hussain (General Counsel)
Karen M Anderson (Insider)
Harris Rotman (SVP)
Learn More about top insider investors at Centessa Pharmaceuticals.
Who are the major institutional investors of Centessa Pharmaceuticals?: Centessa Pharmaceuticals' top institutional investors include:
First Light Asset Management LLC — 4.40%
Price T Rowe Associates Inc. MD — 4.07%
Adage Capital Partners GP L.L.C. — 3.88%
Janus Henderson Group PLC — 3.72%
Farallon Capital Management LLC — 2.65%
Point72 Asset Management L.P. — 2.60%
Learn More about top institutional investors of Centessa Pharmaceuticals stock.
Which institutional investors are selling Centessa Pharmaceuticals stock?: Within the previous quarter, CNTA stock was sold by these institutional investors:
Avidity Partners Management LP
Driehaus Capital Management LLC
Balyasny Asset Management L.P.
5AM Venture Management LLC
Bank of America Corp DE
Silverarc Capital Management LLC
T. Rowe Price Investment Management Inc.
First Light Asset Management LLC
During the previous year, company insiders that have sold Centessa Pharmaceuticals company stock include:
Saurabh Saha (CEO)
Antoine Yver (EVP)
Gregory M Weinhoff (Insider)
David M Chao (Insider)
Tia L Bush (Insider)
Tia L Bush (CTO)
Learn More investors selling Centessa Pharmaceuticals stock.
Which institutional investors are buying Centessa Pharmaceuticals stock?: Within the previous quarter, CNTA stock was purchased by institutional investors including:
Janus Henderson Group PLC
Foresite Capital Management VI LLC
Adage Capital Partners GP L.L.C.
Point72 Asset Management L.P.
Price T Rowe Associates Inc. MD
Farallon Capital Management LLC
Stempoint Capital LP
Schonfeld Strategic Advisors LLC